Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trial.
暂无分享，去创建一个
Wan-Jen Hong | Shaji K. Kumar | P. Moreau | S. Harrison | J. Ross | E. Punnoose | K. Freise | P. Maciag | J. de la Rubia | V. Hungria | H. Salwender | M. Cavo | M. Jalaluddin | Kenshi Suzuki | C. Gasparetto | R. Popat | J. Ward | Xiaoqing Yang | A. Sood | Inho Kim | I. Kim | W. Hong | Inho Kim | Inho Kim | S. Harrison